Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study Ivan Netuka, MD, PhD, Pierre-Yves Litzler, MD, PhD, Michael Berchtold-Herz, MD, Erwan Flecher, MD, Daniel Zimpfer, MD, Laura Damme, RN, MPH, Kartik S. Sundareswaran, PhD, David J. Farrar, PhD, Jan D. Schmitto, MD The Annals of Thoracic Surgery Volume 103, Issue 4, Pages 1262-1268 (April 2017) DOI: 10.1016/j.athoracsur.2016.07.072 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Distribution of international normalized ratio (INR) values during the STudy of Reduced Anti-Coagulation/Anti-platelet Therapy in Patients with the HeartMatE II (TRACE). The Annals of Thoracic Surgery 2017 103, 1262-1268DOI: (10.1016/j.athoracsur.2016.07.072) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Changes in antithrombotic therapy from reduced antithrombotic (RT) initiation to data cutoff. (AVK = vitamin K antagonist.) The Annals of Thoracic Surgery 2017 103, 1262-1268DOI: (10.1016/j.athoracsur.2016.07.072) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Freedom from (A) bleeding and (B) hemorrhagic stroke after reduced antithrombotic therapy (RT) initiation. The Annals of Thoracic Surgery 2017 103, 1262-1268DOI: (10.1016/j.athoracsur.2016.07.072) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Freedom from (A) ischemic stroke and (B) pump thrombosis after reduced antithrombotic therapy (RT) initiation. The Annals of Thoracic Surgery 2017 103, 1262-1268DOI: (10.1016/j.athoracsur.2016.07.072) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 5 Lactate dehydrogenase (LDH) plots for patients enrolled in the study. The Annals of Thoracic Surgery 2017 103, 1262-1268DOI: (10.1016/j.athoracsur.2016.07.072) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions